Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-12-18 Sale |
2024-12-19 6:30 pm |
Design Therapeutics Inc. | DSGN | Prasad Deepa Director |
3,806 | $6.27 | $23,864 | 20,000 (Direct) |
View |
2024-08-09 Sale |
2024-08-12 4:30 pm |
Design Therapeutics Inc. | DSGN | William Arsani Director |
814,874 | $4.25 | $3,463,215 | 4,217,627 (Indirect) |
View |
2024-03-22 Purchase |
2024-03-25 7:10 pm |
Design Therapeutics Inc. | DSGN | Schmid John P. Director |
26,965 | $3.6988 | $99,738 | 57,639 (Indirect Direct) |
View |
2024-03-25 Purchase |
2024-03-25 7:09 pm |
Design Therapeutics Inc. | DSGN | Berger Heather A. Director |
1,300 | $3.7429 | $4,866 | 1,300 (Direct) |
View |
2023-09-29 Purchase |
2023-10-02 6:01 pm |
Design Therapeutics Inc. | DSGN | LAPPE RODNEY W Director |
21,000 | $2.347 | $49,287 | 133,024 (Direct) |
View |
2021-03-30 Purchase(A) |
2023-09-06 5:13 pm |
Design Therapeutics Inc. | DSGN | William Arsani Director |
700,000 | $20 | $14,000,000 | 700,000 (Indirect) |
View |
2023-08-29 Purchase |
2023-08-30 6:06 pm |
Design Therapeutics Inc. | DSGN | Prasad Deepa Director |
12,000 | $2.3058 | $27,670 | 23,806 (Direct) |
View |
2023-08-28 Purchase |
2023-08-30 6:02 pm |
Design Therapeutics Inc. | DSGN | William Arsani Director |
2,235,000 | $2.4043 | $5,373,650 | 5,032,501 (Indirect) |
View |
2022-12-19 Purchase |
2022-12-21 5:00 pm |
Design Therapeutics Inc. | DSGN | Siffert Joao MD President and CEO |
7,450 | $8.3897 | $62,503 | 132,619 (Direct) |
View |
2022-12-16 Purchase |
2022-12-20 6:45 pm |
Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner |
900,000 | $8.4156 | $7,574,078 | 6,526,476 (Indirect) |
View |
2022-12-16 Purchase |
2022-12-20 6:37 pm |
Design Therapeutics Inc. | DSGN | SR One Capital Fund I Aggregator LP SR ONE CAPITAL PARTNERS I LP SR ONE CAPITAL MANAGEMENT LLC 10% Owner |
900,000 | $8.4156 | $7,574,078 | 6,526,476 (Direct) |
View |
2022-12-09 Purchase |
2022-12-12 5:22 pm |
Design Therapeutics Inc. | DSGN | LAPPE RODNEY W Director |
15,000 | $7.9617 | $119,426 | 112,024 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-02 Option Award |
2025-01-06 7:00 pm |
N/A 2035-01-01 |
Design Therapeutics Inc. | DSGN | LAPPE RODNEY W Director |
25,993 | $0 | 25,993 (Direct) |
View |
2025-01-02 Option Award |
2025-01-06 7:00 pm |
N/A 2035-01-01 |
Design Therapeutics Inc. | DSGN | Burgess Julie Chief Accounting Officer |
135,000 | $0 | 135,000 (Direct) |
View |
2025-01-02 Option Award |
2025-01-06 7:00 pm |
N/A 2035-01-01 |
Design Therapeutics Inc. | DSGN | Shah Pratik President, CEO and Chairperson |
600,000 | $0 | 600,000 (Direct) |
View |
2025-01-02 Option Award |
2025-01-06 7:00 pm |
N/A 2035-01-01 |
Design Therapeutics Inc. | DSGN | Jeffries Sean Chief Operating Officer |
260,000 | $0 | 260,000 (Direct) |
View |
2024-06-13 Option Award |
2024-06-17 5:06 pm |
N/A 2034-06-12 |
Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner |
19,000 | $0 | 19,000 (Direct) |
View |
2024-06-13 Option Award |
2024-06-17 5:00 pm |
N/A 2034-06-12 |
Design Therapeutics Inc. | DSGN | William Arsani Director |
19,000 | $0 | 19,000 (Direct) |
View |
2024-06-13 Option Award |
2024-06-17 5:00 pm |
N/A 2034-06-12 |
Design Therapeutics Inc. | DSGN | LAPPE RODNEY W Director |
19,000 | $0 | 19,000 (Direct) |
View |
2024-06-13 Option Award |
2024-06-17 5:00 pm |
N/A 2034-06-12 |
Design Therapeutics Inc. | DSGN | Schmid John P. Director |
19,000 | $0 | 19,000 (Direct) |
View |
2024-06-13 Option Award |
2024-06-17 5:00 pm |
N/A 2034-06-12 |
Design Therapeutics Inc. | DSGN | Berger Heather A. Director |
19,000 | $0 | 19,000 (Direct) |
View |
2024-06-13 Option Award |
2024-06-17 5:00 pm |
N/A 2034-06-12 |
Design Therapeutics Inc. | DSGN | Prasad Deepa Director |
19,000 | $0 | 19,000 (Direct) |
View |
Ownership |
2024-03-20 7:57 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | Kim Jae B. Chief Medical Officer |
0 | $0 | 609,756 (Direct) |
View |
2024-01-02 Option Award |
2024-01-05 4:41 pm |
N/A 2034-01-01 |
Design Therapeutics Inc. | DSGN | Burgess Julie Chief Accounting Officer |
110,000 | $0 | 110,000 (Direct) |
View |
2024-01-02 Option Award |
2024-01-05 4:40 pm |
N/A 2034-01-01 |
Design Therapeutics Inc. | DSGN | Jeffries Sean Chief Operating Officer |
350,000 | $0 | 350,000 (Direct) |
View |
2023-12-01 Option Award |
2023-12-05 7:00 pm |
N/A 2033-11-30 |
Design Therapeutics Inc. | DSGN | LAPPE RODNEY W Director |
69,186 | $0 | 69,186 (Direct) |
View |
2023-12-01 Option Award |
2023-12-05 6:57 pm |
N/A 2033-11-30 |
Design Therapeutics Inc. | DSGN | Ansari Aseem Z. 10% Owner |
100,000 | $0 | 100,000 (Direct) |
View |
2021-03-30 Conversion(A) |
2023-09-06 5:13 pm |
N/A N/A |
Design Therapeutics Inc. | DSGN | William Arsani Director |
2,032,501 | $0 | 700,000 (Indirect) |
View |
2023-09-01 Option Award |
2023-09-05 5:33 pm |
N/A 2033-08-31 |
Design Therapeutics Inc. | DSGN | Shah Pratik President, CEO and Chairperson |
2,100,000 | $0 | 2,100,000 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 4:48 pm |
N/A 2033-05-30 |
Design Therapeutics Inc. | DSGN | George Simeon Director 10% Owner |
15,000 | $0 | 15,000 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 4:31 pm |
N/A 2033-05-30 |
Design Therapeutics Inc. | DSGN | Prasad Deepa Director |
15,000 | $0 | 15,000 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 4:31 pm |
N/A 2033-05-30 |
Design Therapeutics Inc. | DSGN | Schmid John P. Director |
15,000 | $0 | 15,000 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 4:31 pm |
N/A 2033-05-30 |
Design Therapeutics Inc. | DSGN | Xu Stella Director |
15,000 | $0 | 15,000 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 4:31 pm |
N/A 2033-05-30 |
Design Therapeutics Inc. | DSGN | William Arsani Director |
15,000 | $0 | 15,000 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 4:31 pm |
N/A 2033-05-30 |
Design Therapeutics Inc. | DSGN | Berger Heather A. Director |
15,000 | $0 | 15,000 (Direct) |
View |
2023-05-31 Option Award |
2023-06-02 4:31 pm |
N/A 2033-05-30 |
Design Therapeutics Inc. | DSGN | LAPPE RODNEY W Director |
15,000 | $0 | 15,000 (Direct) |
View |
2023-02-01 Option Award |
2023-02-03 4:43 pm |
N/A 2033-01-31 |
Design Therapeutics Inc. | DSGN | Burgess Julie Chief Accounting Officer |
75,000 | $0 | 75,000 (Direct) |
View |
2023-02-01 Option Award |
2023-02-03 4:41 pm |
N/A 2033-01-31 |
Design Therapeutics Inc. | DSGN | Jeffries Sean Chief Operating Officer |
140,000 | $0 | 140,000 (Direct) |
View |
2023-02-01 Option Award |
2023-02-03 4:40 pm |
N/A 2033-01-31 |
Design Therapeutics Inc. | DSGN | Shah Pratik Executive Chairperson |
415,000 | $0 | 415,000 (Direct) |
View |
2023-02-01 Option Award |
2023-02-03 4:39 pm |
N/A 2033-01-31 |
Design Therapeutics Inc. | DSGN | Siffert Joao MD President and CEO |
415,000 | $0 | 415,000 (Direct) |
View |